Marimed (MRMD) Cash from Investing Activities (2012 - 2026)
Marimed (MRMD) posted quarterly Cash from Investing Activities of -$753000.0 for Q1 2026, down 554.78% year-over-year from $165573.6 in Q1 2025, and down 282.23% quarter-over-quarter from -$197000.0 in Q4 2025.
Marimed (MRMD) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Marimed (MRMD) has reported Cash from Investing Activities for 15 consecutive years, with -$753000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 554.78% year-over-year to -$753000.0; the TTM figure through Mar 2026 stood at -$2.0 million (up 84.46% YoY), while the FY2025 annual figure was -$1.4 million, up 91.95% from the prior year.
- Cash from Investing Activities retreated to -$753000.0 in Q1 2026 per MRMD's latest filing, from -$197000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$115000.0 in Q1 2025 and bottomed at -$16.7 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$4.2 million across 5 years, with a median of -$2.6 million in 2022.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities surged 97.3% — and 2026, when it plunged 554.78%.
- Marimed's Cash from Investing Activities stood at -$2.5 million in 2022, then sank by 152.61% to -$6.3 million in 2023, then soared by 81.1% to -$1.2 million in 2024, then jumped by 83.58% to -$197000.0 in 2025, then plunged by 282.23% to -$753000.0 in 2026.
- Business Quant data shows MRMD's Cash from Investing Activities at -$753000.0 in Q1 2026, -$197000.0 in Q4 2025, and -$514000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | -507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -507,000.00 |
| Jun 30, 2026 | -507,000.00 |
| Mar 31, 2026 | -753,000.00 |
| Mar 31, 2026 | -753,000.00 |
| Dec 31, 2025 | -197,000.00 |
| Dec 31, 2025 | -197,000.00 |
| Sep 30, 2025 | -514,000.00 |
| Sep 30, 2025 | -514,000.00 |
| Jun 30, 2025 | -554,000.00 |
| Jun 30, 2025 | -554,000.00 |
| Mar 31, 2025 | -115,000.00 |
| Mar 31, 2025 | -115,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Mar 31, 2024 | -4.27 Mn |
| Mar 31, 2024 | -4.27 Mn |